A Cross-sectional Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS)

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome

NCT00239265 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

NCT00840645 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy and Safety of NDS-446 in Men With Lower Urinary Tract Symptoms (LUTS)

NCT02808013 ·Status: UNKNOWN ·Phase: PHASE2

Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients

NCT00985387 ·Status: COMPLETED

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

NCT03602508 ·Status: COMPLETED

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

NCT01627145 ·Status: UNKNOWN ·Phase: NA

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01043666 ·Status: COMPLETED ·Phase: PHASE3

Developing a Simple Test to Diagnose Overactive Bladder

NCT05572918 ·Status: UNKNOWN

A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

NCT00410514 ·Status: COMPLETED ·Phase: PHASE2

Sexual Function Trial of Overactive Bladder: Medication Versus PTNS

NCT03500146 ·Status: COMPLETED

A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder

NCT00699049 ·Status: COMPLETED ·Phase: PHASE4

Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.

NCT01282840 ·Status: COMPLETED ·Phase: NA

Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women

NCT03807024 ·Status: COMPLETED

The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)

NCT01533597 ·Status: COMPLETED ·Phase: PHASE4

A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence

NCT01505439 ·Status: COMPLETED ·Phase: PHASE4

Evaluating a Digital Intervention for Overactive Bladder

NCT05170100 ·Status: COMPLETED ·Phase: NA

Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder

NCT01578304 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment

NCT01318837 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.

NCT01458197 ·Status: COMPLETED ·Phase: PHASE2

A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

NCT04562090 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment

NCT01122563 ·Status: COMPLETED

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

NCT02216214 ·Status: COMPLETED ·Phase: PHASE4

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

NCT00561951 ·Status: COMPLETED ·Phase: PHASE2

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134 ·Status: COMPLETED ·Phase: PHASE2

A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

NCT00189800 ·Status: COMPLETED ·Phase: PHASE3